GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

nimotuzumab   Click here for help

GtoPdb Ligand ID: 7988

Synonyms: h-R3 | THERACIM® | Theraloc®
Approved drug
nimotuzumab is an approved drug (China, India, others (2014))
Compound class: Antibody
Comment: Nimotuzumab is a monoclonal antibody directed agianst the epidermal growth factor receptor (EGFR), being developed as an antineoplastic agent.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. Peptide sequence analysis using the light chain variable region of nimotuzumab provides a 100% match with sequence 35 from patent US6506883 [1].

Biosimilar drug: Biocon Limited are developing BIOMAb-EGFRTM as a nimotuzumab biosimilar
Classification Click here for help
Compound class Antibody
Approved drug? Yes. China NMPA (2014)  |  India CDSCO (2014)  |  Others (2014)
International Nonproprietary Names Click here for help
INN number INN
8545 nimotuzumab
Synonyms Click here for help
h-R3 | THERACIM® | Theraloc®
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 76
Other databases
GtoPdb PubChem SID 249565669
Search PubMed clinical trials nimotuzumab
Search PubMed titles nimotuzumab
Search PubMed titles/abstracts nimotuzumab
Wikipedia Nimotuzumab